Oncotarget is a free to access online medical journal that is published weekly by Impact Journals. The weekly issue can be availed in hard copy following special requests. The journal was founded in 2010 after the founders realized a gap in the way scientific research findings were reaching the people. Oncotarget was created on a mission of availing scientific results timely and to a wider group of people.
Oncotarget is led by top scientists with remarkable hands-on experience. Mikhail Blagosklonny, a well-known scientist and former oncology professor and Andrei V. Gudkov, a cancer researcher and college professor are the journal’s editors-in-chief. The papers published in the journal are peer-reviewed, leaving no room for mistakes. The review also ensures that the scientific results leave the impact that they were intended to. Oncotarget hopes to one day achieve a life without diseases. Though the journey is long, so much more like fighting diseases through the use of basic clinical science has been accomplished. The researchers have also had an opportunity to play a part in the growth of science. The journal endeavors to unite the different fields of sciences by eliminating the divides between them.
Going Beyond Oncology
Initially, Oncotarget was focused on the treatments and therapies of cancer with the aim of improving the lives of cancer patients. The research conducted was directed at establishing the basis of the cancer therapies in the market and those in the pipeline. Over the years and after marking tremendous success, Oncotarget diversified the coverage to include other areas of science. Currently, the journal accepts papers on Pathology, Immunology, Neurotarget, Microbiology Autophagy, Cell Death, Circadian Rhythm, and neuroscience. By including other fields of science, Oncotarget has created a one-stop shop for people needing medical information on different ailments.
Oncotarget has enjoyed great reception by the people who use the information contained in the journal. Consequently, many lives have been improved. The remarkable work at the firm received many praises and accolades. In 2013, some of the members at Oncotarget were awarded the Breakthrough Prize, an award that is considered to be a top honor. The members were Michael N. Hall, Bert Vogelstein, Alexander Varshavsky, and Stephen J. Elledge.